Moreover, analysis of CTCs isolated from the blood of three patients with CRC (CTC31, CTC44, and CTC45) showed that they all expressed TGFBI and were responsive to TGF-β1 exposure. The gene discussed is TGFBI; the disease is colorectal carcinoma.